Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Helsinki - Delayed Quote EUR

Faron Pharmaceuticals Oy (FARON.HE)

2.4150
-0.0250
(-1.02%)
At close: 6:29:58 PM GMT+3
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
18,673
18,673
28,567
27,426
21,109
Operating Income
-18,673
-18,673
-28,567
-27,426
-21,109
Net Non Operating Interest Income Expense
-7,242
-4,366
-2,341
-1,349
-230
Pretax Income
-25,915
-25,915
-30,944
-28,730
-21,178
Tax Provision
5
5
--
--
16
Net Income Common Stockholders
-25,920
-25,920
-30,944
-28,730
-21,194
Diluted NI Available to Com Stockholders
-25,920
-25,920
-30,944
-28,730
-21,194
Basic EPS
-0.29
--
-0.40
-0.43
-0.35
Diluted EPS
-0.29
--
-0.40
-0.43
-0.35
Basic Average Shares
88,518.6540
--
78,306.9870
66,480.3560
61,056.6230
Diluted Average Shares
88,518.6540
--
78,306.9870
66,480.3560
61,056.6230
Total Operating Income as Reported
-18,673
-18,673
-28,568
-27,426
-21,108
Rent Expense Supplemental
--
246
320
114
7
Total Expenses
18,673
18,673
28,567
27,426
21,109
Net Income from Continuing & Discontinued Operation
-25,920
-25,920
-30,944
-28,730
-21,194
Normalized Income
-25,920
-23,564.8000
-30,902
-28,730
-21,194
Interest Income
434
93
230
11
2
Interest Expense
7,676
3,944
2,125
1,373
215
Net Interest Income
-7,242
-4,366
-2,341
-1,349
-230
EBIT
-18,239
-21,971
-28,819
-27,357
-20,963
EBITDA
-17,925
-21,656
-28,473
-27,057
-20,657
Reconciled Depreciation
314
315
346
300
306
Net Income from Continuing Operation Net Minority Interest
-25,920
-25,920
-30,944
-28,730
-21,194
Total Unusual Items Excluding Goodwill
--
-2,944
-42
--
--
Total Unusual Items
--
-2,944
-42
--
--
Normalized EBITDA
-17,925
-18,712
-28,431
-27,057
-20,657
Tax Rate for Calcs
0.0002
0.0002
--
--
0.0002
Tax Effect of Unusual Items
--
-588.8000
--
--
--
12/31/2021 - 12/3/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HRTIS.HE Herantis Pharma Oyj
1.4050
-2.77%
 
NANOFH.HE Nanoform Finland Oyj
1.0380
-0.19%
 
BIOBV.HE Biohit Oyj
2.5520
-0.97%
 
CAMX.ST Camurus AB (publ)
588.00
+1.29%
 
AMPE Ampio Pharmaceuticals, Inc.
0.0217
-0.23%
 
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
 
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
 
NXOA.BE Nicox SA
0.2260
0.00%
 
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
 
0M4.DU Mersana Therapeutics Inc
0.3383
+0.06%